The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-chloro-3-methyl-phenyl)-5-nitro-1H-benzimidazole ID: ALA4791269
PubChem CID: 162672211
Max Phase: Preclinical
Molecular Formula: C14H10ClN3O2
Molecular Weight: 287.71
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)ccc1Cl
Standard InChI: InChI=1S/C14H10ClN3O2/c1-8-6-9(2-4-11(8)15)14-16-12-5-3-10(18(19)20)7-13(12)17-14/h2-7H,1H3,(H,16,17)
Standard InChI Key: WFPICOYODRRXCO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
29.6197 -28.9855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6186 -29.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3266 -30.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3248 -28.5766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0334 -28.9819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0337 -29.8051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8167 -30.0592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3004 -29.3931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8163 -28.7273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1143 -29.3914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5226 -30.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3390 -30.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7482 -29.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3349 -28.6824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5199 -28.6858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9119 -28.5771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9117 -27.7599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.2043 -28.9858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7408 -27.9731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5654 -29.3909 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
1 16 1 0
16 17 1 0
16 18 2 0
14 19 1 0
13 20 1 0
M CHG 2 16 1 17 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 287.71Molecular Weight (Monoisotopic): 287.0462AlogP: 4.10#Rotatable Bonds: 2Polar Surface Area: 71.82Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.36CX Basic pKa: 3.28CX LogP: 4.34CX LogD: 4.34Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.57Np Likeness Score: -1.87
References 1. Moningka R,Romero FA,Hastings NB,Guo Z,Wang M,Di Salvo J,Li Y,Trusca D,Deng Q,Tong V,Terebetski JL,Ball RG,Ujjainwalla F. (2020) Fragment-based lead discovery of a novel class of small molecule antagonists of neuropeptide B/W receptor subtype 1 (GPR7)., 30 (23): [PMID:32898693 ] [10.1016/j.bmcl.2020.127510 ]